Ming Zhang
Impact in
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
Papers in
-
- Head and Neck Cancer Studies 42
- Oncology 71
- Inflammatory Biomarkers in Disease Prognosis 8
- Cancer Immunotherapy and Biomarkers 8
- Co-authors
- Lei TaoLiang ZhouKhashayarsha KhazaieHongli GongChi‐Yao HsuehYihui ShiJohn KaravitisLaura M. Hix
- Journals
- Acta Oto-Laryngologica (6 papers)The Laryngoscope (4 papers)Journal of Cancer Research and Clinical Oncology (4 papers)Clinical Cancer Research (3 papers)BMC Cancer (3 papers)
- Partner nations
- ChinaUnited StatesOman
In The Last Decade
Ming Zhang
159 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 126
- Otorhinolaryngology 217
- Oncology 1.2k
- Cancer Research 466
- Immunology 467
- Pulmonary and Respiratory Medicine 588
Countries citing papers authored by Ming Zhang
This map shows the geographic impact of Ming Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Zhang more than expected).
Fields of papers citing papers by Ming Zhang
This network shows the impact of papers produced by Ming Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Zhang. The network helps show where Ming Zhang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ming Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 8 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 19 | |
| 7 | 2022 | 5 | |
| 8 | 2022 | 25 | |
| 9 | 2022 | 2 | |
| 10 | 2022 | 2 | |
| 11 | 2022 | 3 | |
| 12 | 2021 | 11 | |
| 13 | 2021 | 7 | |
| 14 | 2020 | 6 | |
| 15 | 2017 | 80 | |
| 16 | 2017 | 1 | |
| 17 | 2015 | 74 | |
| 18 | 2013 | 80 | |
| 19 | 2013 | 5 | |
| 20 | Clinical Study of Treatmeat with Combination of Paclitaxel and Carboplatin in Elderly Patients with Advanced non-small Cell Lung Cancer | 2006 | 1 |
About Ming Zhang
Ming Zhang is a scholar working on Otorhinolaryngology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Surgery, having authored 167 papers that have together received 2.7k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (42 papers), Head and Neck Surgical Oncology (14 papers), Lung Cancer Diagnosis and Treatment (12 papers), Salivary Gland Tumors Diagnosis and Treatment (11 papers), Cancer-related molecular mechanisms research (10 papers), Gastric Cancer Management and Outcomes (9 papers), Inflammatory Biomarkers in Disease Prognosis (8 papers) and Cancer Immunotherapy and Biomarkers (8 papers). The work is most often cited by research in Otorhinolaryngology (217 citations), Oncology (1.2k citations), Cancer Research (466 citations), Immunology (467 citations) and Pulmonary and Respiratory Medicine (588 citations). Ming Zhang has collaborated with scholars based in China, United States and Oman. Frequent co-authors include Lei Tao, Liang Zhou, Khashayarsha Khazaie, Hongli Gong, Chi‐Yao Hsueh, Yihui Shi, John Karavitis, Laura M. Hix, Yingwei Xue and Guanyu Zhu. Their work appears in journals such as Acta Oto-Laryngologica, The Laryngoscope, Journal of Cancer Research and Clinical Oncology, Clinical Cancer Research and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.